Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-15

Clinical Trial Update: The Effects of Low Dose Atropine on Choroidal Thickness [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of low-dose atropine on choroidal thickness in myopia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atropine (low-dose) (Atropine)

Snippet

Sponsor: State University of New York College of Optometry | Conditions: Myopia | Phase 4 | Status: COMPLETED